Neoadjuvant Study of Targeting ROS1 in Combination With Endocrine Therapy in Invasive Lobular Carcinoma of the Breast (ROSALINE)

Clinical trial NCT04551495 · UNKNOWN

Trial details

NCT number: NCT04551495
Sponsor: Jules Bordet Institute
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Invasive Lobular Breast Carcinoma ER+ Breast Cancer HER2-negative Breast Cancer

Start date: 2021-01-14
Primary completion: 2025-01-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.